103 related articles for article (PubMed ID: 3386830)
1. Multisystem triglyceride storage disease is due to a specific defect in the degradation of endocellularly synthesized triglycerides.
Di Donato S; Garavaglia B; Strisciuglio P; Borrone C; Andria G
Neurology; 1988 Jul; 38(7):1107-10. PubMed ID: 3386830
[TBL] [Abstract][Full Text] [Related]
2. Neutral lipid storage disease with ichthyosis: lipid content and metabolism of fibroblasts.
Williams ML; Monger DJ; Rutherford SL; Hincenbergs M; Rehfeld SJ; Grunfeld C
J Inherit Metab Dis; 1988; 11(2):131-43. PubMed ID: 3139924
[TBL] [Abstract][Full Text] [Related]
3. Neutral lipid storage disease: a possible functional defect in phospholipid- linked triacylglycerol metabolism.
Williams ML; Coleman RA; Placezk D; Grunfeld C
Biochim Biophys Acta; 1991 Feb; 1096(2):162-9. PubMed ID: 2001430
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of 1-pyrenedecanoic acid and accumulation of neutral fluorescent lipids in cultured fibroblasts of multisystemic lipid storage myopathy.
Radom J; Salvayre R; Maret A; Nègre A; Douste-Blazy L
Biochim Biophys Acta; 1987 Jul; 920(2):131-9. PubMed ID: 3607075
[TBL] [Abstract][Full Text] [Related]
5. Extracellular origin of the lipid lysosomal storage in cultured fibroblasts from Wolman's disease.
Salvayre R; Negre A; Maret A; Radom J; Douste-Blazy L
Eur J Biochem; 1987 Dec; 170(1-2):453-8. PubMed ID: 3691534
[TBL] [Abstract][Full Text] [Related]
6. Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts.
Igal RA; Coleman RA
J Biol Chem; 1996 Jul; 271(28):16644-51. PubMed ID: 8663220
[TBL] [Abstract][Full Text] [Related]
7. The turnover of cytoplasmic triacylglycerols in human fibroblasts involves two separate acyl chain length-dependent degradation pathways.
Hilaire N; Salvayre R; Thiers JC; Bonnafé MJ; Nègre-Salvayre A
J Biol Chem; 1995 Nov; 270(45):27027-34. PubMed ID: 7592952
[TBL] [Abstract][Full Text] [Related]
8. Independence of triacylglycerol-containing compartments in cultured fibroblasts from Wolman disease and multisystemic lipid storage myopathy.
Salvayre R; Nègre A; Radom J; Douste-Blazy L
FEBS Lett; 1989 Jun; 250(1):35-9. PubMed ID: 2737299
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride storage disease. A group of inborn errors of triglyceride metabolism.
Galton DJ; Gilbert C; Reckless JP; Kaye J
Q J Med; 1974 Jan; 43(169):63-71. PubMed ID: 4362787
[No Abstract] [Full Text] [Related]
10. Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus-transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects.
Radom J; Salvayre R; Levade T; Douste-Blazy L
Biochem J; 1990 Jul; 269(1):107-13. PubMed ID: 2165389
[TBL] [Abstract][Full Text] [Related]
11. Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidation.
Angelini C; Philippart M; Borrone C; Bresolin N; Cantini M; Lucke S
Ann Neurol; 1980 Jan; 7(1):5-10. PubMed ID: 7362208
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and ultrastructural features of human fibroblasts cultured from a new variant of type 3 lipid storage myopathy.
Radom J; Salvayre R; Mussini JM; De Lisle B; Negre A; Maret A; Billaudel S; Douste-Blazy L
Biol Cell; 1988; 62(1):39-45. PubMed ID: 3365518
[TBL] [Abstract][Full Text] [Related]
13. The hypertriglyceridaemias: a heterogeneous group of metabolic disorders.
Galton DJ; Clifton-Bligh P; Reckless JP
Biochem Soc Trans; 1976; 4(4):585-9. PubMed ID: 187483
[No Abstract] [Full Text] [Related]
14. Cellular uptake and catabolism of high-density-lipoprotein triacylglycerols in human cultured fibroblasts: degradation block in neutral lipid storage disease.
Hilaire N; Nègre-Salvayre A; Salvayre R
Biochem J; 1994 Feb; 297 ( Pt 3)(Pt 3):467-73. PubMed ID: 8110183
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
Jones PM; Butt Y; Bennett MJ
Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
[TBL] [Abstract][Full Text] [Related]
16. Neutral-lipid storage disease: a new disorder of lipid metabolism.
Chanarin I; Patel A; Slavin G; Wills EJ; Andrews TM; Stewart G
Br Med J; 1975 Mar; 1(5957):553-5. PubMed ID: 1139147
[No Abstract] [Full Text] [Related]
17. Cholesterol ester storage disease in an adult presenting with sea-blue histiocytosis.
Besley GT; Broadhead DM; Lawlor E; McCann SR; Dempsey JD; Drury MI; Crowe J
Clin Genet; 1984 Sep; 26(3):195-203. PubMed ID: 6478639
[TBL] [Abstract][Full Text] [Related]
18. An enzyme histochemical and ultrastructural study on cultured fibroblasts: a new triglyceride storage disorder.
Sethi NC; Moynahan EJ; Stimmler L
Indian Pediatr; 1982 May; 19(5):401-6. PubMed ID: 7141653
[No Abstract] [Full Text] [Related]
19. Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts an adrenal cortex.
Singh I; Moser HW; Moser AB; Kishimoto Y
Biochem Biophys Res Commun; 1981 Oct; 102(4):1223-9. PubMed ID: 6797420
[No Abstract] [Full Text] [Related]
20. Identification of propionate as a degradation product of phytanic acid oxidation in rat and human tissues.
Hutton D; Steinberg D
J Biol Chem; 1973 Oct; 248(19):6871-5. PubMed ID: 4745448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
